Welcome to DukeHealth.org.
Skip over navigation
Skip over navigation
- Home
- Patient and Visitor Info
- Physicians
- Services
- Clinical Trials
- Event Calendar
- Locations
- Health Library
- About Duke Medicine
Quick Links
Home
>
Clinical Trials
>
Radiographic and Clinical Study Evaluating a Novel Allogenic, Cancellous, Bone Matrix Containing Viable Stem and Osteoprogenitor Cells (Trinity Evolution Viable Cryopreserved Cellular Bone Matrix) in Posterior Lumbar or Transforaminal Lumbar Interbody Fusion (PLIF or TLIF)
Radiographic and Clinical Study Evaluating a Novel Allogenic, Cancellous, Bone Matrix Containing Viable Stem and Osteoprogenitor Cells (Trinity Evolution Viable Cryopreserved Cellular Bone Matrix) in Posterior Lumbar or Transforaminal Lumbar Interbody Fusion (PLIF or TLIF)
Share
This is a post-market study where Trinity Evolution is used in conjunction with an interbody spacer and supplemental posterior fixation of the surgeon's choice and to follow the patients to measure the clinical outcomes and rate of fusion.
Eligibility Requirements
Patients must be at least 18 years of age or older.
Study Requirements
- Patients will be followed for two years.
- This is a multi-site study with an estimated target accrual of 200 patients.
Compensation
$50 gift card
For more information, contact Carlos A. Bagley,MD, at 919-668-6760.
(REF# 18961)
